Who have Faecal incontinence with Multiple sclerosis - from FDA reports

Faecal incontinence is found among people with Multiple sclerosis, especially for people who are female, 50-59 old, take medication Tysabri and have Depression. This study is created by eHealthMe based on reports of 914 people who have Multiple sclerosis from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Jan, 24, 2019

914 people who have Multiple Sclerosis and Faecal Incontinence are studied.

Number of reports submitted per year:

Would you have Faecal incontinence when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Faecal Incontinence *:

  • female: 76.1 %
  • male: 23.9 %

Age of people who have Multiple Sclerosis and experience Faecal Incontinence *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.27 %
  • 20-29: 4.7 %
  • 30-39: 12.75 %
  • 40-49: 29.13 %
  • 50-59: 31.81 %
  • 60+: 21.34 %

Top co-existing conditions for these people *:

  1. Depression: 24 people, 2.63%
  2. Pain: 23 people, 2.52%
  3. Stress And Anxiety: 15 people, 1.64%
  4. Muscle Spasms (muscle contraction): 15 people, 1.64%
  5. Gait Disturbance: 9 people, 0.98%
  6. Constipation: 9 people, 0.98%
  7. High Blood Pressure: 9 people, 0.98%
  8. Insomnia (sleeplessness): 8 people, 0.88%
  9. Fatigue (feeling of tiredness): 7 people, 0.77%
  10. Diabetes: 6 people, 0.66%

Most common drugs for these people *:

  1. Tysabri: 322 people, 35.23%
  2. Avonex: 291 people, 31.84%
  3. Rebif: 116 people, 12.69%
  4. Tecfidera: 89 people, 9.74%
  5. Aubagio: 52 people, 5.69%
  6. Gilenya: 44 people, 4.81%
  7. Baclofen: 40 people, 4.38%
  8. Neurontin: 40 people, 4.38%
  9. Copaxone: 37 people, 4.05%
  10. Betaseron: 28 people, 3.06%

Top symptoms for these people *:

  1. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 371 people, 40.59%
  2. Weakness: 185 people, 20.24%
  3. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 171 people, 18.71%
  4. Fall: 167 people, 18.27%
  5. Fatigue (feeling of tiredness): 163 people, 17.83%
  6. Gait Disturbance: 140 people, 15.32%
  7. Diarrhea: 139 people, 15.21%
  8. Memory Loss: 133 people, 14.55%
  9. Urinary Tract Infection: 110 people, 12.04%
  10. Headache (pain in head): 101 people, 11.05%

* Approximation only. Some reports may have incomplete information.

Do you have Faecal incontinence with Multiple sclerosis?

You are not alone:

Related studies

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen (latest reports from 541,645 Multiple sclerosis patients)

Faecal Incontinence

Faecal incontinence (a lack of control over passing stool) has been reported by people with multiple sclerosis, high blood pressure, depression, pain, osteoporosis (latest reports from 8,183 Faecal incontinence patients).

Drugs that are associated with Faecal incontinence
Faecal incontinence (1,712 drugs)
Other conditions that could cause Faecal incontinence
Faecal incontinence (1,170 conditions)
Browse all symptoms of Multiple sclerosis
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!